Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (15157)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 28, 2016 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sforza V, Martinelli E, Ciardiello F, Gambardella V, Napolitano S, Martini G, della Corte C, Cardone C, Ferrara ML, Reginelli A, Liguori G, Belli G, Troiani T. Mechanisms of resistance to anti-epidermal growth factor receptor inhibitors in metastatic colorectal cancer. World J Gastroenterol 2016; 22(28): 6345-6361 [PMID: 27605871 DOI: 10.3748/wjg.v22.i28.6345] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i28/6345.htm |
| Number | Citing Articles |
| 1 |
Fanny Ledys, Valentin Derangère, Manon Réda, Jean-Florian Guion, Romily Milliex, Valérie Roux, Emeric Limagne, Laurent Arnould, Leila Bengrine, François Ghiringhelli, Cédric Rébé. Anti-MEK and Anti-EGFR mAbs in RAS-Mutant Metastatic Colorectal Cancer: Case Series and Rationale. Advances in Therapy 2019; 36(6): 1480 doi: 10.1007/s12325-019-00949-y
|
| 2 |
David Zahavi, Louis Weiner. Monoclonal Antibodies in Cancer Therapy. Antibodies 2020; 9(3): 34 doi: 10.3390/antib9030034
|
| 3 |
Richard M. Goldberg, Clara Montagut, Zev A. Wainberg, Philippe Ronga, Françis Audhuy, Julien Taieb, Sebastian Stintzing, Salvatore Siena, Daniele Santini. Optimising the use of cetuximab in the continuum of care for patients with metastatic colorectal cancer. ESMO Open 2018; 3(4): e000353 doi: 10.1136/esmoopen-2018-000353
|
| 4 |
Yanpeng Xing, Hongyu Jing, Ye Zhang, Jian Suo, Ming Qian. MicroRNA-141-3p affected proliferation, chemosensitivity, migration and invasion of colorectal cancer cells by targeting EGFR. The International Journal of Biochemistry & Cell Biology 2020; 118: 105643 doi: 10.1016/j.biocel.2019.105643
|
| 5 |
Ying Zhang, Jin-An Ma, Hai-Xia Zhang, Yu-Na Jiang, Wen-Hao Luo. Cancer vaccines: Targeting KRAS-driven cancers. Expert Review of Vaccines 2020; 19(2): 163 doi: 10.1080/14760584.2020.1733420
|
| 6 |
Julie Joseph, Grace Sandel, Ratuja Kulkarni, Reem Alatrash, Bobby Brooke Herrera, Pooja Jain. Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS. Pathogens 2023; 13(1): 14 doi: 10.3390/pathogens13010014
|
| 7 |
Evangelos Koustas, Michalis V. Karamouzis, Chrysovalantou Mihailidou, Dimitrios Schizas, Athanasios G. Papavassiliou. Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer. Cancer Letters 2017; 396: 94 doi: 10.1016/j.canlet.2017.03.023
|
| 8 |
S. Napolitano, N. Matrone, A. L. Muddassir, G. Martini, A. Sorokin, V. De Falco, E. F. Giunta, D. Ciardiello, E. Martinelli, V. Belli, M. Furia, S. Kopetz, F. Morgillo, F. Ciardiello, T. Troiani. Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1497-0
|
| 9 |
Sandra Kannampuzha, Abilash Valsala Gopalakrishnan. Cancer chemoresistance and its mechanisms: Associated molecular factors and its regulatory role. Medical Oncology 2023; 40(9) doi: 10.1007/s12032-023-02138-y
|
| 10 |
|
| 11 |
Jeremy Jeack Ceen Ng, Zhi Xuan Low, Larsen Alessandro, Jung Yin Fong, Audrey Onn Yi Au Yong, Minn-E Ng, Michelle Yee Mun Teo, Hok Chai Yam, Lionel Lian Aun In. Recombinant cell penetrating peptides and intrabodies targeting membrane-bound mutated KRAS antigens. Asia Pacific Journal of Molecular Biology and Biotechnology 2022; : 54 doi: 10.35118/apjmbb.2022.030.2.06
|
| 12 |
Ke-Tao Jin, Bo Chen, Yu-Yao Liu, H uan-Rong Lan, Jie-Ping Yan. Monoclonal antibodies and chimeric antigen receptor (CAR) T cells in the treatment of colorectal cancer. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-01763-9
|
| 13 |
Dennis Krieg, Gerhard Winter, Hristo L. Svilenov. It is Never Too Late for a Cocktail - Development and Analytical Characterization of Fixed-dose Antibody Combinations. Journal of Pharmaceutical Sciences 2022; 111(8): 2149 doi: 10.1016/j.xphs.2022.05.014
|
| 14 |
Harshabad Singh, Ashley Kang, Lisa Bloudek, Ling-I Hsu, Maria Corinna Palanca-Wessels, Michael Stecher, Muriel Siadak, Kimmie Ng. Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer. JNCI Cancer Spectrum 2024; 8(1) doi: 10.1093/jncics/pkad082
|
| 15 |
Christine M. Parseghian, Stefania Napolitano, Jonathan M. Loree, Scott Kopetz. Mechanisms of Innate and Acquired Resistance to Anti-EGFR Therapy: A Review of Current Knowledge with a Focus on Rechallenge Therapies. Clinical Cancer Research 2019; 25(23): 6899 doi: 10.1158/1078-0432.CCR-19-0823
|
| 16 |
Lei Yang, Nigora Atakhanova, Meryelem Tania Churampi Arellano, Mohammed Yassen Mohamed, Thamer Hani, Ali A. Fahdil, Roxana Yolanda Castillo-Acobo, Ashima Juyal, Ahlam Kadhim Hussein, Ali H. Amin, Renzon Daniel Cosme Pecho, Reza Akhavan-Sigari. Translational research of new developments in targeted therapy of colorectal cancer. Pathology - Research and Practice 2023; 252: 154888 doi: 10.1016/j.prp.2023.154888
|
| 17 |
Gun Min Youn, Ayden G. Case, Trent Jarin, BaoXiang Li, Aditi Swarup, Andrea Naranjo, Charbel Bou-Khalil, Jacqueline Yao, Quan Zhou, Marisa E. Hom, Eben L. Rosenthal, Albert Y. Wu. The Use of Panitumumab-IRDye800CW in a Novel Murine Model for Conjunctival Squamous Cell Carcinoma. Translational Vision Science & Technology 2022; 11(7): 23 doi: 10.1167/tvst.11.7.23
|
| 18 |
Zeba Siddiqui, Sumaiya Ahmed, Michael Vickers. Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesaemia: Is There a Best Replacement Strategy?. European Medical Journal 2021; doi: 10.33590/emj/21-00083
|
| 19 |
Yu-Chen S. H. Yang, Po-Jui Ko, Yi-Shin Pan, Hung-Yun Lin, Jacqueline Whang-Peng, Paul J. Davis, Kuan Wang. Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers. Journal of Biomedical Science 2021; 28(1) doi: 10.1186/s12929-021-00719-5
|
| 20 |
Fatemeh Keshavarz, Mohsen Soltanshahi, Fatemeh Khosravani, Farzaneh Bakhshiyan, Amir Ghanbari, Sajad Hassanzadeh, Mozhgan Amirpour, Ghasem Ghalamfarsa. Thymol-loaded liposomes effectively induced apoptosis and decreased EGFR expression in colorectal cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; doi: 10.1007/s00210-024-02945-8
|
| 21 |
Guillermo Valenzuela, Mauricio Burotto, Katherine Marcelain, Jaime González-Montero. Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer. World Journal of Gastrointestinal Oncology 2022; 14(9): 1654-1664 doi: 10.4251/wjgo.v14.i9.1654
|
| 22 |
Jiawei Zhou, Can Liu, Yu Tang, Zhongbo Li, Yanguang Cao. Phenotypic switching as a non-genetic mechanism of resistance predicts antibody therapy regimens. iScience 2024; 27(4): 109450 doi: 10.1016/j.isci.2024.109450
|
| 23 |
Xuefeng He, Xinyang Zhong, Zijuan Hu, Senlin Zhao, Ping Wei, Dawei Li. An insight into small extracellular vesicles: Their roles in colorectal cancer progression and potential clinical applications. Clinical and Translational Medicine 2020; 10(8) doi: 10.1002/ctm2.249
|
| 24 |
Haogang Zhang, Yaguang Zong, Gongcai Qiu, Ruichun Jia, Xunzheng Xu, Fujing Wang, Dequan Wu. Silencing Lin28 promotes apoptosis in colorectal cancer cells by upregulating let‑7c targeting of antiapoptotic BCL2L1. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.8483
|
| 25 |
Rida Fatima Saeed, Uzma Azeem Awan, Sidra Saeed, Sara Mumtaz, Nosheen Akhtar, Shaista Aslam. Therapeutic Approaches in Cancer Treatment. Cancer Treatment and Research 2023; 185: 177 doi: 10.1007/978-3-031-27156-4_10
|
| 26 |
Guannan Zhu, Zijun Wu, Su Lui, Na Hu, Min Wu. Advances in Imaging Modalities and Contrast Agents for the Early Diagnosis of Colorectal Cancer. Journal of Biomedical Nanotechnology 2021; 17(4): 558 doi: 10.1166/jbn.2021.3064
|
| 27 |
Pietro Paolo Vitiello, Claudia Cardone, Giulia Martini, Davide Ciardiello, Valentina Belli, Nunzia Matrone, Giusi Barra, Stefania Napolitano, Carmina Della Corte, Mimmo Turano, Maria Furia, Teresa Troiani, Floriana Morgillo, Ferdinando De Vita, Fortunato Ciardiello, Erika Martinelli. Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1035-0
|
| 28 |
A. Trullas, J. Delgado, J. Koenig, U. Fuerstenau, J. Dedorath, S. Hausmann, T. Stock, H. Enzmann, F. Pignatti. The EMA assessment of encorafenib in combination with cetuximab for the treatment of adult patients with metastatic colorectal carcinoma harbouring the BRAFV600E mutation who have received prior therapy. ESMO Open 2021; 6(1): 100031 doi: 10.1016/j.esmoop.2020.100031
|
| 29 |
Katsuhiro Uzawa, Antonio L. Amelio, Atsushi Kasamatsu, Tomoaki Saito, Akihiro Kita, Megumi Fukamachi, Yuki Sawai, Yuriko Toeda, Keitaro Eizuka, Fumihiko Hayashi, Ikuko Kato-Kase, Masataka Sunohara, Manabu Iyoda, Kazuyuki Koike, Dai Nakashima, Katsunori Ogawara, Yosuke Endo-Sakamoto, Masashi Shiiba, Yuichi Takiguchi, Mitsuo Yamauchi, Hideki Tanzawa. Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-48717-w
|
| 30 |
Mikyung Kelly Seo, John Cairns, Aamir Ahmad. Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer. PLOS ONE 2018; 13(9): e0204496 doi: 10.1371/journal.pone.0204496
|
| 31 |
Iris van 't Erve, Marjolein J.E. Greuter, Karen Bolhuis, Daan C.L. Vessies, Alessandro Leal, Geraldine R. Vink, Daan van den Broek, Victor E. Velculescu, Cornelis J.A. Punt, Gerrit A. Meijer, Veerle M.H. Coupé, Remond J.A. Fijneman. Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal Cancer. The Journal of Molecular Diagnostics 2020; 22(12): 1430 doi: 10.1016/j.jmoldx.2020.09.002
|
| 32 |
R. Danesi, S. Fogli, S. Indraccolo, M. Del Re, A.P. Dei Tos, L. Leoncini, L. Antonuzzo, L. Bonanno, V. Guarneri, A. Pierini, G. Amunni, P. Conte. Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards. ESMO Open 2021; 6(2): 100040 doi: 10.1016/j.esmoop.2020.100040
|
| 33 |
Andrew C Nelson, Jamie Boone, David Cartwright, Bharat Thyagarajan, Robyn Kincaid, Aaron P Lambert, Kylene Karnuth, Christine Henzler, Sophia Yohe. Optimal detection of clinically relevant mutations in colorectal carcinoma: sample pooling overcomes intra-tumoral heterogeneity. Modern Pathology 2018; 31(2): 343 doi: 10.1038/modpathol.2017.120
|
| 34 |
Enric Domingo, Carme Camps, Pamela J Kaisaki, Marie J Parsons, Dmitri Mouradov, Melissa M Pentony, Seiko Makino, Michelle Palmieri, Robyn L Ward, Nicholas J Hawkins, Peter Gibbs, Hanne Askautrud, Dahmane Oukrif, Haitao Wang, Joe Wood, Evie Tomlinson, Yasmine Bark, Kulvinder Kaur, Elaine C Johnstone, Claire Palles, David N Church, Marco Novelli, Havard E Danielsen, Jon Sherlock, David Kerr, Rachel Kerr, Oliver Sieber, Jenny C Taylor, Ian Tomlinson. Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series. The Lancet Gastroenterology & Hepatology 2018; 3(9): 635 doi: 10.1016/S2468-1253(18)30117-1
|
| 35 |
Kouki Okita, Kazuki Imai, Kazunori Kato, Reiko Sugiura, Yuichi Endo, Kazue Masuko, Yoshihisa Tomioka, Takashi Masuko. Altered binding avidities and improved growth inhibitory effects of novel anti-HER3 mAb against human cancers in the presence of HER1-or HER2-targeted drugs. Biochemical and Biophysical Research Communications 2021; 576: 59 doi: 10.1016/j.bbrc.2021.08.091
|
| 36 |
Giulia Martini, Teresa Troiani, Claudia Cardone, Pietropaolo Vitiello, Vincenzo Sforza, Davide Ciardiello, Stefania Napolitano, Carminia Maria Della Corte, Floriana Morgillo, Antonio Raucci, Antonio Cuomo, Francesco Selvaggi, Fortunato Ciardiello, Erika Martinelli. Present and future of metastatic colorectal cancer treatment: A review of new candidate targets. World Journal of Gastroenterology 2017; 23(26): 4675-4688 doi: 10.3748/wjg.v23.i26.4675
|
| 37 |
Erika Martinelli, Teresa Troiani, Vincenzo Sforza, Giulia Martini, Claudia Cardone, PietroPaolo Vitiello, Davide Ciardiello, AnnaMaria Rachiglio, Nicola Normanno, Andrea Sartore-Bianchi, Silvia Marsoni, Alberto Bardelli, Salvatore Siena, Fortunato Ciardiello. Sequential HER2 blockade as effective therapy in chemorefractory, HER2 gene-amplified, RAS wild-type, metastatic colorectal cancer: learning from a clinical case. ESMO Open 2018; 3(1): e000299 doi: 10.1136/esmoopen-2017-000299
|
| 38 |
Umbreen Hafeez, Hui K Gan, Andrew M Scott. Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases. Current Opinion in Pharmacology 2018; 41: 114 doi: 10.1016/j.coph.2018.05.010
|
| 39 |
Mostafa Akbarzadeh Khiavi, Azam Safary, Jaleh Barar, Amir Ajoolabady, Mohammad Hossein Somi, Yadollah Omidi. Multifunctional nanomedicines for targeting epidermal growth factor receptor in colorectal cancer. Cellular and Molecular Life Sciences 2020; 77(6): 997 doi: 10.1007/s00018-019-03305-z
|
| 40 |
Raja Jouini, Marwa Ferchichi, Ehsen BenBrahim, Imen Ayari, Fatma Khanchel, Wafa Koubaa, Olfa Saidi, Riadh Allani, Aschraf Chadli-Debbiche. KRAS and NRAS pyrosequencing screening in Tunisian colorectal cancer patients in 2015. Heliyon 2019; 5(3): e01330 doi: 10.1016/j.heliyon.2019.e01330
|
| 41 |
Dong Young Kang, Nipin Sp, Eun Seong Jo, Alexis Rugamba, Dae Young Hong, Hong Ghi Lee, Ji-Seung Yoo, Qing Liu, Kyoung-Jin Jang, Young Mok Yang. The Inhibitory Mechanisms of Tumor PD-L1 Expression by Natural Bioactive Gallic Acid in Non-Small-Cell Lung Cancer (NSCLC) Cells. Cancers 2020; 12(3): 727 doi: 10.3390/cancers12030727
|
| 42 |
David I. Cantor, Harish R. Cheruku, Jack Westacott, Joo-Shik Shin, Abidali Mohamedali, Seong Boem Ahn. Proteomic investigations into resistance in colorectal cancer. Expert Review of Proteomics 2020; 17(1): 49 doi: 10.1080/14789450.2020.1713103
|
| 43 |
Winnie Fong, Kenneth K. W. To. Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cellular and Molecular Life Sciences 2019; 76(17): 3383 doi: 10.1007/s00018-019-03134-0
|
| 44 |
Vincenza Granata, Roberta Fusco, Antonio Avallone, Orlando Catalano, Francesco Filice, Maddalena Leongito, Raffaele Palaia, Francesco Izzo, Antonella Petrillo. Major and ancillary magnetic resonance features of LI-RADS to assess HCC: an overview and update. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0132-y
|
| 45 |
Laura J. Tafe. Molecular mechanisms of therapy resistance in solid tumors: chasing “moving” targets. Virchows Archiv 2017; 471(2): 155 doi: 10.1007/s00428-017-2101-7
|
| 46 |
Felix Wong, Oana Coban, Gregory Weitsman, Tony Ng. Integrating imaging, exosome and protein network rewiring information to track early tumour evolution of resistance mechanisms. Convergent Science Physical Oncology 2017; 3(1): 013004 doi: 10.1088/2057-1739/aa5cbd
|
| 47 |
|
| 48 |
Mohammad Amin Kerachian, Ali Poudineh, Jean Paul Thiery. Cell free circulating tumor nucleic acids, a revolution in personalized cancer medicine. Critical Reviews in Oncology/Hematology 2019; 144: 102827 doi: 10.1016/j.critrevonc.2019.102827
|
| 49 |
Selma Ahcene Djaballah, Francesca Daniel, Anna Milani, Gianmarco Ricagno, Sara Lonardi. HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target. American Society of Clinical Oncology Educational Book 2022; (42): 219 doi: 10.1200/EDBK_351354
|
| 50 |
Evangelos Koustas, Athanasios G. Papavassiliou, Michalis V. Karamouzis, Vladimir Trajkovic. The role of autophagy in the treatment of BRAF mutant colorectal carcinomas differs based on microsatellite instability status. PLOS ONE 2018; 13(11): e0207227 doi: 10.1371/journal.pone.0207227
|
| 51 |
G. Wang, Y. He, Y. Sun, W. Wang, X. Qian, X. Yu, Y. Pan. Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer. Clinical and Translational Oncology 2020; 22(6): 813 doi: 10.1007/s12094-019-02213-9
|
| 52 |
Stefania Napolitano, Giulia Martini, Erika Martinelli, Valentina Belli, Alessia Parascandolo, Mikko O. Laukkanen, Vincenzo Sforza, Floriana Morgillo, Davide Ciardiello, Fortunato Ciardiello, Teresa Troiani. Therapeutic efficacy of SYM004, a mixture of two anti-EGFR antibodies in human colorectal cancer with acquired resistance to cetuximab and MET activation. Oncotarget 2017; 8(40): 67592 doi: 10.18632/oncotarget.18749
|
| 53 |
Ioannis A. Voutsadakis. The Landscape of PIK3CA Mutations in Colorectal Cancer. Clinical Colorectal Cancer 2021; 20(3): 201 doi: 10.1016/j.clcc.2021.02.003
|
| 54 |
Jianliang Zhang, Irwin H. Gelman, Jun Qu, Steven N. Hochwald. Phosphohistidine signaling promotes FAK-RB1 interaction and growth factor-independent proliferation of esophageal squamous cell carcinoma. Oncogene 2023; 42(6): 449 doi: 10.1038/s41388-022-02568-4
|
| 55 |
Federica Finetti, Lucrezia Paradisi, Clizia Bernardi, Margherita Pannini, Lorenza Trabalzini. Cooperation between Prostaglandin E2 and Epidermal Growth Factor Receptor in Cancer Progression: A Dual Target for Cancer Therapy. Cancers 2023; 15(8): 2374 doi: 10.3390/cancers15082374
|
| 56 |
Stefania Napolitano, Teresa Troiani, Erika Martinelli, Fortunato Ciardiello. Towards the era of precision medicine in metastatic colorectal cancer. ESMO Open 2020; 5(2): e000685 doi: 10.1136/esmoopen-2020-000685
|
| 57 |
Claudia Cardone, Bernadette Blauensteiner, Veronica Moreno-Viedma, Giulia Martini, Vittorio Simeon, Pietro P. Vitiello, Davide Ciardiello, Valentina Belli, Nunzia Matrone, Teresa Troiani, Floriana Morgillo, Federica Zito Marino, Monica Dentice, Annarita Nappi, Alessandra Boccaccino, Carlotta Antoniotti, Chiara Cremolini, Filippo Pietrantonio, Gerald W. Prager, Nicola Normanno, Evaristo Maiello, Guillem Argiles, Elena Elez, Giuseppe Signoriello, Renato Franco, Alfredo Falcone, Josep Tabernero, Maria Sibilia, Fortunato Ciardiello, Erika Martinelli. AXL is a predictor of poor survival and of resistance to anti-EGFR therapy in RAS wild-type metastatic colorectal cancer. European Journal of Cancer 2020; 138: 1 doi: 10.1016/j.ejca.2020.07.010
|
| 58 |
Guangyao Li, Tian Li, Wenyan Fu, Changhai Lei, Shi Hu. Novel Sensitizing Agents for Therapeutic Anti-EGFR Antibodies. 2023; : 35 doi: 10.1016/B978-0-12-821584-5.00026-2
|
| 59 |
Alfonso Reginelli, Angelo Vanzulli, Cristiano Sgrazzutti, Luca Caschera, Nicola Serra, Antonio Raucci, Fabrizio Urraro, Salvatore Cappabianca. Vascular microinvasion from hepatocellular carcinoma: CT findings and pathologic correlation for the best therapeutic strategies. Medical Oncology 2017; 34(5) doi: 10.1007/s12032-017-0949-7
|
| 60 |
Hakan Gurdal, Matilda Tuglu, Saber Bostanabad, Başak Dalkili�. Partial agonistic effect of cetuximab on epidermal growth factor receptor and Src kinase activation in triple‑negative breast cancer cell lines. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4697
|
| 61 |
Lorenzo Mortara, Marzia B. Gariboldi, Annalisa Bosi, Marco Bregni, Graziella Pinotti, Luigina Guasti, Alessandro Squizzato, Douglas M. Noonan, Elena Monti, Leonardo Campiotti. Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells. Targeted Oncology 2018; 13(5): 657 doi: 10.1007/s11523-018-0586-x
|
| 62 |
Juanzi Zeng, Wenwei Fan, Jiaquan Li, Guowu Wu, Heming Wu. KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer. International Journal of General Medicine 2023; : 4109 doi: 10.2147/IJGM.S428580
|
| 63 |
Jiahao Han, Xiangyu Wang, Chong Zhang, Qian Wu, Xiaochen Ma, Yitong Li, Zhenmei Chen, Rui Zhang, Guo Zhang, Jing Lin, Lu Lu, Wenwei Zhu, Huliang Jia, Jubo Zhang, Jie Fan, Jinhong Chen. Clinicopathological and prognostic significance of HER2 status in surgically resected colorectal liver metastases. Journal of Surgical Oncology 2022; 125(6): 991 doi: 10.1002/jso.26815
|
| 64 |
Alfonso Reginelli, Alfredo Clemente, Claudia Cardone, Fabrizio Urraro, Andrea Izzo, Erika Martinelli, Teresa Troiani, Fortunato Ciardiello, Luca Brunese, Salvatore Cappabianca. Computed tomography densitometric study of anti-angiogenic effect of regorafenib in colorectal cancer liver metastasis. Future Oncology 2018; 14(28): 2905 doi: 10.2217/fon-2017-0687
|
| 65 |
Gianluca Pellino, Gaetano Gallo, Pierlorenzo Pallante, Raffaella Capasso, Alfonso De Stefano, Isacco Maretto, Umberto Malapelle, Shengyang Qiu, Stella Nikolaou, Andrea Barina, Giuseppe Clerico, Alfonso Reginelli, Antonio Giuliani, Guido Sciaudone, Christos Kontovounisios, Luca Brunese, Mario Trompetto, Francesco Selvaggi. Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/2397863
|
| 66 |
Martini Giulia, Troiani Teresa, Cardone Claudia, Vitiello Pietro Paolo, Ciardiello Davide, Morgillo Floriana, Ciardiello Fortunato, Martinelli Erika. Anti-angiogenic Treatment in Metastatic Colorectal Cancer: Current Issues and Future Aims. Current Cancer Therapy Reviews 2019; 15(3): 184 doi: 10.2174/1573394714666181119145327
|
| 67 |
Giulia Martini, Davide Ciardiello, Pietro Paolo Vitiello, Stefania Napolitano, Claudia Cardone, Antonio Cuomo, Teresa Troiani, Fortunato Ciardiello, Erika Martinelli. Resistance to anti-epidermal growth factor receptor in metastatic colorectal cancer: What does still need to be addressed?. Cancer Treatment Reviews 2020; 86: 102023 doi: 10.1016/j.ctrv.2020.102023
|
| 68 |
Mamoon Ur Rashid, Ishtiaq Hussain, Sundas Jehanzeb, Saeed Ali, Akriti Gupta Jain, Ranjeet Kumar, Neelam Khetpal, Sarfraz Ahmad. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 115 doi: 10.1007/978-981-13-1486-5_10
|
| 69 |
Mary Luz Uribe, Ilaria Marrocco, Yosef Yarden. EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance. Cancers 2021; 13(11): 2748 doi: 10.3390/cancers13112748
|
| 70 |
Krizelle Mae M. Alcantara, Joshua Reginald P. Malapit, Ryan Timothy D. Yu, Jose Antonio Ma. G. Garrido, John Paul T. Rigor, Arlou Kristina J. Angeles, Eva Maria Cutiongco-de la Paz, Reynaldo L. Garcia. Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants. Cells 2019; 8(12): 1557 doi: 10.3390/cells8121557
|
| 71 |
Iris van 't Erve, Jamie E. Medina, Alessandro Leal, Eniko Papp, Jillian Phallen, Vilmos Adleff, Elaine Jiayuee Chiao, Adith S. Arun, Karen Bolhuis, John K. Simmons, Aanavi Karandikar, Kenneth C. Valkenburg, Mark Sausen, Samuel V. Angiuoli, Robert B. Scharpf, Cornelis J.A. Punt, Gerrit A. Meijer, Victor E. Velculescu, Remond J.A. Fijneman. Metastatic Colorectal Cancer Treatment Response Evaluation by Ultra-Deep Sequencing of Cell-Free DNA and Matched White Blood Cells. Clinical Cancer Research 2023; 29(5): 899 doi: 10.1158/1078-0432.CCR-22-2538
|
| 72 |
Silvia García-Roman, Mónica Garzón-Ibáñez, Jordi Bertrán-Alamillo, Núria Jordana-Ariza, Ana Giménez-Capitán, Beatriz García-Peláez, Marta Vives-Usano, Jordi Codony-Servat, Erik d'Hondt, Rafael Rosell, Miguel Ángel Molina-Vila. Vaccine antibodies against a synthetic epidermal growth factor variant enhance the antitumor effects of inhibitors targeting the MAPK/ERK and PI3K/Akt pathways. Translational Oncology 2024; 40: 101878 doi: 10.1016/j.tranon.2024.101878
|
| 73 |
Le Fu, Linan Zhao, Fei Li, Feng Wen, Peng Zhang, Xia Yang, Yuanqiang Wang. Pharmacological mechanism of quercetin in the treatment of colorectal cancer by network pharmacology and molecular simulation. Journal of Biomolecular Structure and Dynamics 2023; : 1 doi: 10.1080/07391102.2023.2235589
|
| 74 |
David J. Zahavi, Rossin Erbe, Yong-Wei Zhang, Theresa Guo, Zoe X. Malchiodi, Rachael Maynard, Alexander Lekan, Rosa Gallagher, Julia Wulfkuhle, Emanuel Petricoin, Sandra A. Jablonski, Elana J. Fertig, Louis M. Weiner. Antibody dependent cell-mediated cytotoxicity selection pressure induces diverse mechanisms of resistance. Cancer Biology & Therapy 2023; 24(1) doi: 10.1080/15384047.2023.2269637
|
| 75 |
Ali Azadi, Alireza Golchini, Sina Delazar, Fatemeh Abarghooi Kahaki, Seyed Mohsen Dehnavi, Zahra Payandeh, Shirin Eyvazi. Recent Advances on Immune Targeted Therapy of Colorectal Cancer Using bi-Specific Antibodies and Therapeutic Vaccines. Biological Procedures Online 2021; 23(1) doi: 10.1186/s12575-021-00147-7
|
| 76 |
Naoki Kiyota, Kazuhiko Namekata, Euido Nishijima, Xiaoli Guo, Atsuko Kimura, Chikako Harada, Toru Nakazawa, Takayuki Harada. Effects of constitutively active K-Ras on axon regeneration after optic nerve injury. Neuroscience Letters 2023; 799: 137124 doi: 10.1016/j.neulet.2023.137124
|
| 77 |
Yi-Hsuan Huang, Peng-Chan Lin, Wu-Chou Su, Ren-Hao Chan, Po-Chuan Chen, Bo-Wen Lin, Meng-Ru Shen, Shang-Hung Chen, Yu-Min Yeh. Association between Altered Oncogenic Signaling Pathways and Overall Survival of Patients with Metastatic Colorectal Cancer. Diagnostics 2021; 11(12): 2308 doi: 10.3390/diagnostics11122308
|
| 78 |
Stefania Napolitano, Giulia Martini, Erika Martinelli, Carminia Maria Della Corte, Floriana Morgillo, Valentina Belli, Claudia Cardone, Nunzia Matrone, Fortunato Ciardiello, Teresa Troiani. Antitumor efficacy of triple monoclonal antibody inhibition of epidermal growth factor receptor (EGFR) with MM151 in EGFR-dependent and in cetuximab-resistant human colorectal cancer cells. Oncotarget 2017; 8(47): 82773 doi: 10.18632/oncotarget.19797
|
| 79 |
Valentina Belli, Vincenzo Sforza, Claudia Cardone, Erika Martinelli, Giusi Barra, Nunzia Matrone, Stefania Napolitano, Floriana Morgillo, Concetta Tuccillo, Alessandro Federico, Marcello Dallio, Carmelina Loguercio, Antonietta Gerarda Gravina, Raffaele De Palma, Fortunato Ciardiello, Teresa Troiani. Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer. Oncotarget 2017; 8(40): 68305 doi: 10.18632/oncotarget.20054
|
| 80 |
Patricia F. de Souza Oliveira, Alessandra V. S. Faria, Stefano P. Clerici, Erica M. Akagi, Hernandes F. Carvalho, Giselle Z. Justo, Nelson Durán, Carmen V. Ferreira‐Halder. Violacein negatively modulates the colorectal cancer survival and epithelial–mesenchymal transition. Journal of Cellular Biochemistry 2022; 123(7): 1247 doi: 10.1002/jcb.30295
|
| 81 |
Reham Ajina, David J. Zahavi, Yong-Wei Zhang, Louis M. Weiner. Overcoming malignant cell-based mechanisms of resistance to immune checkpoint blockade antibodies. Seminars in Cancer Biology 2020; 65: 28 doi: 10.1016/j.semcancer.2019.12.005
|
| 82 |
Mouade El Bali, Joaira Bakkach, Mohcine Bennani Mechita, Alamgeer Yuchi. Colorectal Cancer: From Genetic Landscape to Targeted Therapy. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/9918116
|
| 83 |
Alfonso Reginelli, Vincenza Granata, Roberta Fusco, Francesco Granata, Daniela Rega, Luca Roberto, Gianluca Pellino, Antonio Rotondo, Francesco Selvaggi, Francesco Izzo, Antonella Petrillo, Roberto Grassi. Diagnostic performance of magnetic resonance imaging and 3D endoanal ultrasound in detection, staging and assessment post treatment, in anal cancer. Oncotarget 2017; 8(14): 22980 doi: 10.18632/oncotarget.14946
|
| 84 |
Susana Olmedillas-López, Mariano García-Arranz, Damián García-Olmo. Current and Emerging Applications of Droplet Digital PCR in Oncology. Molecular Diagnosis & Therapy 2017; 21(5): 493 doi: 10.1007/s40291-017-0278-8
|
| 85 |
E. Martinelli, D. Ciardiello, G. Martini, T. Troiani, C. Cardone, P.P. Vitiello, N. Normanno, A.M. Rachiglio, E. Maiello, T. Latiano, F. De Vita, F. Ciardiello. Implementing anti-epidermal growth factor receptor (EGFR) therapy in metastatic colorectal cancer: challenges and future perspectives. Annals of Oncology 2020; 31(1): 30 doi: 10.1016/j.annonc.2019.10.007
|